Assistant HHS secretary for health has led policy development for several offices since his 2018 confirmation and also has industry and clinical experience.
Adm. Brett Giroir, currently Health and Human Services assistant secretary for health, will become acting US Food and Drug Administration Commissioner, ending the tenure of Norman Sharpless, and giving the agency an experienced political official as its temporary chief.
Giroir became the acting head of the FDA in conjunction with the nomination of Stephen Hahn to be the permanent...
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
